$UTHR SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.54M)
23 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.54M)
22 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.32M)
22 Oct 2026	8-K: Other Events SILVER SPRING, M.D. and RESEARCH TRIANGLE PARK, N.C., October 22, 2026: United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors has authorized a new share repurc...
21 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.26M)
20 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.16M)
19 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.08M)
16 Oct 2026	Form 4: Mahon Paul A, EVP & GENERAL COUNSEL Received 8,300 shares by exercise or conversion ($1.21M) · Sold 8,300 shares ($4.52M)
16 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.19M)
15 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.13M)
15 Oct 2026	144
14 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.18M)
14 Oct 2026	8-K: Other Events This Settlement Agreement (this “Agreement”) is made and entered into as of the last date of signature of this Agreement (the “Execution Date”), by and between United Therapeutics Corporation, a Delaware public benefit corporation with a...
13 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.23M)
13 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.18M)
09 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.08M)
08 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.22M)
07 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.12M)
06 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.15M)
05 Oct 2026	Form 4: Rothblatt Martine A, Director Received 9,500 shares by exercise or conversion ($1.12M) · Sold 9,500 shares ($5.22M)

Comments